Diagnostic accuracy of bone metastases detection in cancer patients: Comparison between bone scintigraphy and whole-body FDG-PET

@article{Fujimoto2006DiagnosticAO,
  title={Diagnostic accuracy of bone metastases detection in cancer patients: Comparison between bone scintigraphy and whole-body FDG-PET},
  author={Ryota Fujimoto and Tatsuya Higashi and Yuji Nakamoto and Tadashi Hara and Andrej Lyshchik and Koichi Ishizu and Hidekazu Kawashima and Shigeto Kawase and Toru Fujita and Tsuneo Saga and Kaori Togashi},
  journal={Annals of Nuclear Medicine},
  year={2006},
  volume={20},
  pages={399-408}
}
Abstract18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) has become widely available and an important oncological technique. To evaluate the influence of PET on detection of bone metastasis, we compared the diagnostic accuracy of PET and conventional bone scintigraphy (BS) in a variety of cancer patients.MethodsConsecutive ninety-five patients with various cancers, who received both PET and BS within one month, were retrospectively analyzed. A whole-body PET (from face to upper… 
Accuracy of Fluorodeoxyglucose-Positron Emission Tomography for Diagnosis of Single Bone Metastasis: Comparison With Bone Scintigraphy
TLDR
Fluorodeoxyglucose-positron emission tomography (FDG-PET) using the semiquantitative parameter SUV improves the diagnostic ability to differentiate between single bone metastases and benign lesions.
Comparison of 18F-FDG-PET/CT with 99mTc-MDP bone scintigraphy for the detection of bone metastases in cancer patients
TLDR
18F-FDG-PET/CT is more sensitive than BS in detecting bone metastasis in patients with neoplastic diseases and has the advantage of detecting unknown primary cancers and visceral metastases besides bone metastases.
Meta-analysis: Comparison of F-18 Fluorodeoxyglucose-Positron Emission Tomography and Bone Scintigraphy in the Detection of Bone Metastases in Patients With Breast Cancer
TLDR
It remains inconclusive whether FDG-PET or bone scintigraphy is superior in detecting osseous metastasis from breast cancer, however, FDg-PET does have a higher specificity and may better serve as a confirmatory test than bone scintsigraphy and used to monitor response to therapy.
Staging PET–CT Scanning Provides Superior Detection of Lymph Nodes and Distant Metastases than Traditional Imaging in Locally Advanced Breast Cancer
TLDR
PET–CT has a role in identifying additional sites of regional lymphadenopathy and distant metastasis to upstage the disease in a significant number of LABC patients in comparison to CI; this would help in accurate staging, selecting optimal treatment, and better prognostication of disease.
The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients
TLDR
F-18 NaF using PET-CT system has significantly better sensitivity and specificity than conventional Tc-99m MDP BS in detecting metastatic HCC bone lesions that are predominantly osteolytic.
Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer.
TLDR
Bone SPECT is superior to FDG PET in detecting bone metastases in breast cancer and the sensitivity of osteoblastic lesions is limited withFDG PET, while surveillance of metastatic spread to the skeleton in Breast cancer patients based on FDGPET alone is not possible.
Metabolic activity in bone metastases of breast and prostate 18 cancer were similar as studied by F-FDG PET / CT . The 99 m role
TLDR
No sign of correlation was noticed in the metabolic activity-glucose utilization of metastatic bone foci between breast and prostate cancer cases and this observation validates the independent value of analyzed diagnostic methods and suggests negligible in uence of glucose utilization in bone 18 re-modeling in the above metastatic cancer cells.
Evaluation of Response to Therapy in a Patient with Lung Cancer: Correlation of Sclerotic Bone Lesions with F 18 FDG PET/CT and Bone Scintigraphy
TLDR
A F 18 FDG negative bone lesion, which is sclerotic on CT, may represent post-treatment osteoblastic change rather than active tumor and BS might play a role in the discrimination of these two situations.
Diagnosis of bone metastases: a meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy
TLDR
PET and MRI were found to be comparable and both significantly more accurate than CT and BS for the diagnosis of bone metastases.
...
...

References

SHOWING 1-10 OF 35 REFERENCES
Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy
TLDR
FDG-PET appears to be a powerful tool not only in the diagnosis of the primary lesion and soft tissue metastasis, but also in the diagnoses of bony metastasis among patients with breast cancer.
Staging non-small cell lung cancer with whole-body PET.
TLDR
Whole-body PET was more accurate than thoracic CT, bone scintigraphy, and brain CT or MR imaging in staging bronchogenic carcinoma.
Comparison of18FDG-PET with99mTc-HMDP scntigraphy for the detection of bone metastases in patients with breast cancer
TLDR
This study shows that 18FDG-PET tends to be superior to bone scintigraphy in the detection of osteolytic lesions, but inferior in the Detection of osteoblastic lesions.
Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer
TLDR
The data suggest that whole-body FDG PET may be useful in detecting bone metastases in patients with known NSCLC.
Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions.
TLDR
18FDG PET is superior to bone scintigraphy in the detection of osteolytic breast cancer metastases, which led to a poorer prognosis than conventional PET, and osteoblastic metastases show lower metabolic activity and are frequently undetectable by PET.
Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer.
TLDR
Bone SPECT is superior to FDG PET in detecting bone metastases in breast cancer and the sensitivity of osteoblastic lesions is limited withFDG PET, while surveillance of metastatic spread to the skeleton in Breast cancer patients based on FDGPET alone is not possible.
Prevalence and Patterns of Bone Metastases Detected with Positron Emission Tomography Using F-18 FDG
TLDR
The most frequent pattern of detectable bone metastases with FDG-PET imaging was multiple foci of intense uptake, which revealed more lesions than did bone scanning, independent of the type of cancer or location of bone involvement, in patients who were accurately diagnosed byFDG- PET imaging.
Positron emission tomography and bone metastases.
The use of 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in the evaluation and management of patients with malignancy continues to increase. However, its role in the
...
...